Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4M Buy
43,734
+14,837
+51% +$5.29M 1.43% 20
2025
Q4
$9.46M Buy
28,897
+96
+0.3% +$30.5K 0.93% 30
2025
Q3
$8.13M Buy
28,801
+242
+0.8% +$70.2K 0.78% 32
2025
Q2
$7.97M Buy
28,559
+724
+3% +$205K 0.85% 32
2025
Q1
$8.67M Buy
27,835
+872
+3% +$257K 1.15% 28
2024
Q4
$7.03M Buy
26,963
+3,460
+15% +$1.03M 0.83% 39
2024
Q3
$5.47M Sell
23,503
-2,260
-9% -$739K 1.5% 26
2024
Q2
$8.05M Buy
25,763
+1,192
+5% +$350K 1.26% 22
2024
Q1
$6.45M Buy
24,571
+24,547
+102,279% +$7.18M 1.75% 21
2023
Q4
$7.05K Sell
24
-24,718
-100% -$6.73M 1.53% 19
2023
Q3
$6.65M Buy
+24,742
New +$6.17M 1.69% 17
2023
Q1
$6.11M Buy
25,256
+685
+3% +$168K 1.58% 20
2022
Q4
$6.45M Buy
24,571
+705
+3% +$189K 1.46% 22
2022
Q3
$5.38M Buy
23,866
+7
+0% +$1.7K 1.4% 23
2022
Q2
$5.8M Buy
23,859
+355
+2% +$87K 1.34% 27
2022
Q1
$5.68M Buy
23,504
+2,344
+11% +$539K 1.09% 33
2021
Q4
$4.76M Buy
21,160
+1,315
+7% +$278K 0.84% 37
2021
Q3
$4.22M Buy
19,845
+214
+1% +$49.3K 0.81% 48
2021
Q2
$4.79M Buy
19,631
+825
+4% +$203K 0.96% 37
2021
Q1
$4.68M Buy
18,806
+1,060
+6% +$253K 1.15% 31
2020
Q4
$4.08M Buy
17,746
+305
+2% +$70.3K 1.07% 36
2020
Q3
$4.43M Sell
17,441
-12
-0.1% -$2.97K 1.29% 28
2020
Q2
$4.12M Sell
17,453
-4,317
-20% -$985K 1.32% 26
2020
Q1
$4.41M Sell
21,770
-2,045
-9% -$447K 1.72% 13
2019
Q4
$5.74M Buy
23,815
+1,384
+6% +$305K 1.76% 16
2019
Q3
$4.34M Buy
22,431
+8,490
+61% +$1.63M 1.44% 23
2019
Q2
$2.57M Buy
13,941
+2,728
+24% +$488K 0.74% 51
2019
Q1
$2.13M Buy
+11,213
New +$2.14M 0.75% 60
2018
Q1
Sell
-15,598
Closed -$2.82M 87
2017
Q4
$2.82M Buy
15,598
+492
+3% +$87.1K 1.25% 32
2017
Q3
$2.8M Buy
15,106
+177
+1% +$31.4K 1.04% 42
2017
Q2
$2.57M Buy
14,929
+3,310
+28% +$538K 1.01% 42
2017
Q1
$1.89M Buy
11,619
+1,214
+12% +$202K 1.16% 35
2016
Q4
$1.61M Sell
10,405
-6,753
-39% -$1.02M 0.77% 48
2016
Q3
$2.86M Buy
+17,158
New +$2.9M 1.57% 22

Other funds holding AMGN

IBEX Wealth Advisors's AMGN Position: Q1 2026 in Review

IBEX Wealth Advisors increased its Amgen (AMGN) stake by 51% in Q1 2026, buying an estimated $5.29M and bringing the position to 43,734 shares worth $15.4M. The position accounts for 1.43% of the portfolio, ranked #20.

IBEX Wealth Advisors first reported a position in AMGN in Q3 2016 and has held it in 34 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • IBEX Wealth Advisors held 43,734 shares of Amgen worth $15.4M as of Q1 2026.
  • IBEX Wealth Advisors bought 14,837 Amgen shares in Q1 2026, an estimated $5.29M.
  • Amgen made up 1.43% of IBEX Wealth Advisors's portfolio in Q1 2026, its #20 holding.
  • IBEX Wealth Advisors first reported a position in Amgen in Q3 2016 and has held it in 34 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on IBEX Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.